LINC01282

Across TCGA pan-cancer cohorts, LINC01282 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01282’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC01282 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01282 is over-expressed in tumor, although a few such as LUAD show the opposite, repressed pattern.

HNSC, THCA, and LUAD are the cancer types where LINC01282 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01282 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.046	<.001	8	view →
THCA	All	All	+0.016	.009	3	view →
LUAD	All	All	−0.043	.029	2	view →
UCEC	All	All	+0.038	.028	2	view →
PRAD	All	All	+0.029	.009	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC01282–HNSC

Open the HNSC breakdown →